home.aspx

 
.

WEST ADDRESSES CHALLENGES FOR ONCOLOGY DRUG DEVELOPMENT & DELIVERY

September 30, 2020
USA
SHARESHARESHARE
Oncology has long been a major focus of R&D activities, and it is projected to be the area with the largest proportion of clinical development spending, with 37% of total pipeline expenditure and 28% of total pipeline FDA approvals, over the next 6 years. Yet, there are many unmet needs for the patient undergoing cancer treatment. Developing improved therapies and providing patients with a choice in the way these therapies are administered are necessary for creating more effective and patient friendly treatments.